Primary Care Medicine: On Demand 2.2
|
$500.00
Use promo code (Limited Offer)
20 CREDITS
 |
|
A collection of clinical lectures from our live meetings selected by your peers as the most relevant and useful for Primary CareCourse Content
| Session | Title | Faculty |
| Session 1 (56 minutes) | Update on Functional Gastrointestinal Disorders for PCP | William D. Chey, MD |
| Session 2 (60 minutes) | Celiac Disease | William D. Chey, MD |
| Session 3 (47 minutes) | Acute Pharyngitis | Robert Dachs, MD, FAAFP |
| Session 4 (59 minutes) | Syncope | Robert Dachs, MD, FAAFP |
| Session 5 (48 minutes) | Acute Stroke Care: Current Controversies | Jim Ducharme, MD CM FRCP |
| Session 6 (64 minutes) | Opioid Prescribing: Achieving the Right Balance | Jim Ducharme, MD CM FRCP |
| Session 7 (64 minutes) | Diagnosis and Treatment of Major Depression in Primary Care Setting | Thomas W. Heinrich, MD, FAPM |
| Session 8 (65 minutes) | The Identification and Treatment of Anxiety Disorders in Primary Care | Thomas W. Heinrich, MD, FAPM |
| Session 9 (54 minutes) | Acne | Jonathan Karnes, MD |
| Session 10 (69 minutes) | Nevi and Melanoma | Jonathan Karnes, MD |
| Session 11 (60 minutes) | Contraceptive Update: New | Anita L. Nelson, MD |
| Session 12 (60 minutes) | Polycystic Ovary Syndrome (PCOS): It's Not as Complicated as it Seems | Anita L. Nelson, MD |
| Session 13 (70 minutes) | Cutaneous Signs of Internal Malignancy | Theodore Rosen, MD |
| Session 14 (49 minutes) | The Itchy Patient: Diagnosis and Therapy | Theodore Rosen, MD |
| Session 15 (64 minutes) | Good Weight Management is Good Diabetes Management | Donna H. Ryan, MD |
| Session 16 (53 minutes) | Drugs, Devices, and Surgery: Essential Knowledge for Weight Management | Donna H. Ryan, MD |
| Session 17 (66 minutes) | How to Navigate the Maze of Diabetes | Jay H. Shubrook, DO FAAFP, FACOFP |
| Session 18 (56 minutes) | 10 Things to Make Diabetes Visits More Effective | Jay H. Shubrook, DO FAAFP, FACOFP |
| Session 19 (53 minutes) | Cases in Rheumatology for the Primary Care Clinician | Alan Stern, MD, MMM, FACR, FACP |
| Session 20 (58 minutes) | Interpreting Lab Results in Rheumatology: What Do I Do Now? | Alan Stern, MD, MMM, FACR, FACP |
Program Overview
Presented by Continuing Education Company (CEC) for the past 26 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recorded video lectures from conferences that took place in 2017. The emphasis of this course is on practical and useful information for clinical practice. This CME program will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice. This activity will highlight the latest science related to a variety of specialty areas, presented in a practical and patient-focused manner relevant to the primary care setting.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Accreditation
AMA PRA Category 1 Credits™: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Continuing Education Company, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 20 hours of Category I credit for completing this activity.
AANPCP: The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Release Date: 8/17/2018
Expiration Date: 8/17/2021
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Ronald Jendry, MD - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Alan Stern MD, MMM, FACR, FACP has no relevant financial relationships to disclose.
- Anita L. Nelson, MD - Speakers Bureau: Allergan, Aspen Pharma, Bayer, Merck; Advisory Board: Agile Pharmaceuticals, Bayer, ContraMed, Intrarosa, Merck; Consultant: Agile Pharmaceuticals, Allergan, Bayer, ContraMed, Intrarosa, Merck; Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received: Agile Pharmaceuticals, Allergan, Bayer, ContraMed, Merck, Honoraria: Agile Pharmaceuticals, Allergan, Aspen Pharma, Bayer, ContraMed, Intrarosa, Merck
- Donna H. Ryan, MD - Speakers Bureau: Eisai, Novo Nordisk, Orexigen Therapeutics, Advisory Board: Eisai, Gila Therapeutics, Janssen, Novo Nordisk, Orexigen Therapeutics, Real Appeal; Consultant: Eisai, Kwangdong, Scientific Intake; Ownership Interest includes stock, stock options, patent or other intellectual property: Gila Therapeutics, Scientific Intake
- Jay H. Shubrook DO FAAFP, FACOFP - Advisory Board: Eli Lilly; Advisory Board: Intarcia Therapeutics; Advisory Board: Novo Nordisk
- Jim Ducharme MD CM FRCP has no relevant financial relationships to disclose.
- Jonathan Karnes, MD has no relevant financial relationships to disclose.
- Robert Dachs, MD, FAAFP has no relevant financial relationships to disclose.
- Theodore Rosen, MD has no relevant financial relationships to disclose.
- Thomas W. Heinrich, MD, FAPM has no relevant financial relationships to disclose.
- William D. Chey, MD has no relevant financial relationships to disclose.
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Conflict of Interest (COI) and Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships which they or their spouse/partner have with (a) with the manufacturer(s) of any commercial products(s) and/or provider(s) of commercial services discussed in an educational presentation and (b) with any commercial supporters of the activity. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All potential conflicts of interest have been identified and resolved, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later